These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23519216)

  • 61. Dexmedetomidine failed to block the acute hyperdynamic response to electroconvulsive therapy.
    Fu W; White PF
    Anesthesiology; 1999 Feb; 90(2):422-4. PubMed ID: 9952147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
    Urban-Kowalczyk M; Rudecki T; Wróblewski D; Smigielski J; Kałużyńska O; Rabe-Jabłońska J
    Neurocase; 2014 Aug; 20(4):452-5. PubMed ID: 23679561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature.
    Gerlach AT; Murphy CV
    Pharmacotherapy; 2009 Dec; 29(12):1492. PubMed ID: 19947809
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electroconvulsive therapy (ECT) after pulmonary edema.
    Bryson EO; Popeo DM; Kellner CH
    J ECT; 2012 Jun; 28(2):e25-6. PubMed ID: 22622302
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy.
    Rasmussen KG; Mueller M; Knapp RG; Husain MM; Rummans TA; Sampson SM; O'Connor MK; Petrides G; Fink M; Kellner CH
    J Clin Psychiatry; 2007 Nov; 68(11):1701-6. PubMed ID: 18052563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electroconvulsive therapy-induced migraine successfully treated with valproic acid.
    Rovers JM; Roks G
    J ECT; 2012 Mar; 28(1):64-5. PubMed ID: 22343586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electroconvulsive therapy as a treatment for protracted refractory delirium in the intensive care unit--five cases and a review.
    Nielsen RM; Olsen KS; Lauritsen AO; Boesen HC
    J Crit Care; 2014 Oct; 29(5):881.e1-6. PubMed ID: 24975569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral.
    Tsaltas E; Kalogerakou S; Papakosta VM; Kontis D; Theochari E; Koutroumpi M; Anyfandi E; Michopoulos I; Poulopoulou C; Papadimitriou G; Oulis P
    Psychol Med; 2011 May; 41(5):983-95. PubMed ID: 20678297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Initial experience with dexmedetomidine in paediatric-aged patients.
    Tobias JD; Berkenbosch JW
    Paediatr Anaesth; 2002 Feb; 12(2):171-5. PubMed ID: 11882231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibitory effects of the alpha-2 adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs.
    Yamakage M; Iwasaki S; Satoh JI; Namiki A
    Eur J Anaesthesiol; 2008 Jan; 25(1):67-71. PubMed ID: 17888193
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    Abe A; Takeda Y; Ishiki H
    JAMA; 2022 Jul; 328(2):213. PubMed ID: 35819432
    [No Abstract]   [Full Text] [Related]  

  • 73. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    Henry PH; Dantz B
    JAMA; 2022 Jul; 328(2):213-214. PubMed ID: 35819431
    [No Abstract]   [Full Text] [Related]  

  • 74. Successful Emergency Treatment of Refractory Neuroleptic Malignant Syndrome With Electroconvulsive Therapy and a Novel Use of Dexmedetomidine: A Case Report From California in the Era of COVID-19.
    Rajan R; Sage M
    J ECT; 2021 Mar; 37(1):71-73. PubMed ID: 33600120
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Acute Agitation Associated With Excited Catatonia Using Dexmedetomidine: Case Series and Literature Review.
    Almeida M; Cicolello K; Hanso A; DeCavalcante G; DeOliveira GS
    Prim Care Companion CNS Disord; 2021 Oct; 23(5):. PubMed ID: 34619813
    [No Abstract]   [Full Text] [Related]  

  • 76. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.
    Preskorn SH; Risinger R; Kakar R
    JAMA; 2022 Jul; 328(2):214-215. PubMed ID: 35819427
    [No Abstract]   [Full Text] [Related]  

  • 77. Use of dexmedetomidine for primary sedation in a general intensive care unit.
    Short J
    Crit Care Nurse; 2010 Feb; 30(1):29-38; quiz 39. PubMed ID: 19875767
    [No Abstract]   [Full Text] [Related]  

  • 78. Dexmedetomidine: a new option for intractable distress in the dying.
    Soares LG; Naylor C; Martins MA; Peixoto G
    J Pain Symptom Manage; 2002 Jul; 24(1):6-8. PubMed ID: 12183087
    [No Abstract]   [Full Text] [Related]  

  • 79. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.
    Venn RM; Hell J; Grounds RM
    Crit Care; 2000; 4(5):302-8. PubMed ID: 11056756
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dexmedetomidine as sole sedative during percutaneous carotid artery stenting in a patient with severe chronic obstructive pulmonary disease.
    Cata JP; Folch E
    Minerva Anestesiol; 2009 Nov; 75(11):668-71. PubMed ID: 19881464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.